Sub menu

 
 

Bayer Australia Limited

Regulatory activities for this sponsor.

Type

Date

17 result(s) found, displaying 1 to 10

  • AusPAR: Finerenone

    Australian Public Assessment Report (AusPAR)
    Kerendia (finerenone) for the treatment of progressive decline of kidney function in adults.

  • Kerendia

    Prescription medicine decision summary
    Australian prescription medicine decision summary

  • AusPAR: Larotrectinib

    Australian Public Assessment Report (AusPAR)
    Australian Public Assessment Report for Larotrectinib

  • AusPAR: Darolutamide

    Australian Public Assessment Report (AusPAR)
    Australian Public Assessment Report for Darolutamide

  • Nubeqa

    Prescription medicine decision summary
    Australian prescription medicine decision summary

  • AusPAR: Aflibercept (rch)

    Australian Public Assessment Report (AusPAR)
    Australian Public Assessment Report for Aflibercept (rch)

  • AusPAR: Riociguat

    Australian Public Assessment Report (AusPAR)
    Australian Public Assessment Report for Riociguat

  • AusPAR: Levonorgestrel

    Australian Public Assessment Report (AusPAR)
    Australian Public Assessment Report for Levonorgestrel

  • AusPAR: Regorafenib

    Australian Public Assessment Report (AusPAR)
    Australian Public Assessment Report for Regorafenib

Help us improve the Therapeutic Goods Administration site